Surgery Partners (SGRY) Receivables (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Receivables data on file, last reported at $603.4 million in Q1 2026.

• Quarterly Receivables rose 5.75% year-over-year to $603.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $603.4 million (up 5.75% YoY) and the FY2025 annual result came in at $602.2 million, up 3.99% from the prior year.
• Receivables held at $603.4 million in Q1 2026 per SGRY's latest filing, from $602.2 million in the prior quarter.
• The five-year high for Receivables was $603.4 million in Q1 2026, with the low at $412.0 million in Q2 2022.
• Average Receivables over 5 years is $507.3 million, with a median of $496.4 million recorded in 2023.
• Year-over-year, Receivables gained 17.31% in 2024 and grew 3.99% in 2025.
• Surgery Partners' Receivables stood at $456.3 million in 2022, then advanced by 8.79% to $496.4 million in 2023, then advanced by 16.66% to $579.1 million in 2024, then gained by 3.99% to $602.2 million in 2025, then advanced by 0.2% to $603.4 million in 2026.
• Business Quant data shows SGRY's Receivables at $603.4 million in Q1 2026, $602.2 million in Q4 2025, and $579.3 million in Q3 2025.